Vector-borne diseases (VBDs) represent a significant public health concern in India, with an increasing burden on the healthcare system. These diseases, transmitted by vectors like mosquitoes, ticks, and fleas, include malaria, dengue, chikungunya, and zika, among others. This article provides a comprehensive overview of the current challenges and potential strategies to address VBDs in India.
The Indian subcontinent's diverse climatic conditions and high population density create an ideal environment for the proliferation of vectors, leading to a high incidence of VBDs. Rapid urbanization, poor sanitation, and climate change further exacerbate the situation. According to the World Health Organization, India accounts for 89% of South-East Asia's malaria burden and 34% of dengue cases worldwide.
The primary challenges in addressing VBDs in India include inadequate surveillance, lack of public awareness, insufficient vector control measures, and limited access to healthcare services. Furthermore, the emergence of vector resistance to insecticides and pathogen resistance to drugs pose significant hurdles.
Effective VBD management necessitates a multi-pronged approach. Strengthening surveillance systems for early detection and prompt response, improving public health infrastructure, and enhancing community awareness are crucial. Additionally, integrated vector management strategies, including biological control measures and the judicious use of insecticides, are needed. Research and development in novel diagnostic tools, vaccines, and therapeutics should be prioritized.
The rising challenge of VBDs in India calls for concerted efforts from healthcare professionals, policymakers, researchers, and the community. While the task is daunting, adopting comprehensive, sustainable, and evidence-based strategies can significantly mitigate the impact of these diseases on public health. Continuing professional education and interdisciplinary collaboration will be key to navigating this complex landscape.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation